KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Cash from Financing Activities (2016 - 2025)

Fulgent Genetics' Cash from Financing Activities history spans 10 years, with the latest figure at -$534000.0 for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 63.3% year-over-year to -$534000.0; the TTM value through Dec 2025 reached -$14.8 million, down 205.12%, while the annual FY2025 figure was -$14.8 million, 205.12% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$534000.0 at Fulgent Genetics, down from -$445000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $47.3 million in Q1 2021 and bottomed at -$35.5 million in Q3 2022.
  • The 5-year median for Cash from Financing Activities is -$1.9 million (2024), against an average of -$3.0 million.
  • The largest annual shift saw Cash from Financing Activities surged 47376.27% in 2021 before it tumbled 1086.42% in 2022.
  • A 5-year view of Cash from Financing Activities shows it stood at $13.2 million in 2021, then tumbled by 324.97% to -$29.6 million in 2022, then increased by 12.31% to -$26.0 million in 2023, then skyrocketed by 98.74% to -$327000.0 in 2024, then plummeted by 63.3% to -$534000.0 in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Cash from Financing Activities are -$534000.0 (Q4 2025), -$445000.0 (Q3 2025), and -$2.6 million (Q2 2025).